Drug-induced immune hemolytic anemia

Expert Opinion on Drug Safety

Volumn 8, Issue 1, 2009, Pages 73-79

  Salama, Abdulgabar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Drug induced; Hemolytic anemia; Immune hemolysis

Indexed keywords

AUTOANTIBODY; BILIRUBIN; CD45 ANTIGEN; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CISPLATIN; DICLOFENAC; FLUDARABINE; HAPTEN; HAPTOGLOBIN; HEMOGLOBIN; IMMUNOGLOBULIN G; LEVODOPA; MEFENAMIC ACID; METHYLDOPA; OXALIPLATIN; PENICILLIN G; QUINIDINE; RIFAMPICIN;

ABDOMINAL PAIN; ANTIBODY PRODUCTION; ANTIBODY SCREENING; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CHILL; CLINICAL FEATURE; COMPLEMENT ACTIVATION; DRUG MEGADOSE; DYSPNEA; ERYTHROCYTE; FEVER; HEADACHE; HEART PALPITATION; HEMATOCRIT; HEMODIALYSIS; HEMOLYSIS; HUMAN; IMMUNE RESPONSE; IMMUNITY; INCIDENCE; INTRAVASCULAR HEMOLYSIS; JAUNDICE; KIDNEY FAILURE; LABORATORY TEST; LOW BACK PAIN; MALAISE; NAUSEA; NONHUMAN; PALLOR; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PLASMAPHERESIS; RETICULOCYTE; REVIEW; SEROLOGY; SHOCK; TACHYCARDIA; URINE COLOR; VOMITING;

ANEMIA, HEMOLYTIC; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; CEPHALOSPORINS; ERYTHROCYTES; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 67549120458     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740330802577351     Document Type: Review

References (77)

1. Snapper I, Marks D, Schwartz L, Hollander L. Hemolytic anemia secondary to mesantoin. Ann Intern Med 1953;39(3):619-623
2. Dausset J, Contu L. Drug-induced hemolysis. Annu Rev Med 1967;18:55-70 • A comprehensive review of drug-induced immune hemolytic anemia.
3. Worlledge SM. Immune drug-induced hemolytic anemias. Semin Hematol 1973;10(4):327-44 • A comprehensive review of drug-induced immune hemolytic anemia.
4. Petz LD, Fundenberg HH. Immunologic mechanisms in drug-induced cytopenias. Prog Hematol 1975;9:185-206 • A comprehensive review of drug-induced immune hemolytic anemia.
5. Petz LD, Garratty G. Aquired immune hemolytic anemias. Churchill livingstone, New York; 1980 •• A detailed analysis of drug-induced immune hemolytic anemia.
6. Ammus S, Yunis AA. Drug-induced red cell dyscrasias. Blood Rev 1989;3(2):71-82 • A comprehensive review of drug-induced immune hemolytic anemia.
7. Petz LD, Garratty G. Immune hemolytic anemias. 2nd edition, Philadephia: Churchill livingstone; 2004 •• A detailed analysis of drug-induced immune hemolytic anemia.
8. Garratty G, Arndt PA. An update on drug-induced immune hemolytic anemia. Immunohematol 2007;23(3):105-19 •• A detailed analysis of drug-induced immune hemolytic anemia.
9. Nordhagen R, Vik H, Wolthuis K, et al. Immune-mediated hemolysis associated with the administration of a radiographic contrast medium. Transfusion 1991;31(9):843-846
10. Munizza M, Kavitsky D, Schainker BA, et al. Hemolytic anemia associated with injection of fluorescein. Transfusion 1993;33(8):689-692 (Pubitemid 23237603)
11. Wolf B, Conradty M, Grohmann R, et al. A case of immune complex hemolytic anemia, thrombocytopenia, and acute renal failure associated with doxepin use. J Clin Psychiatry 1989;50(3):99-100 (Pubitemid 19095869)
12. Guitard M, Giannoli C, Bachet P, Vial T. Ambroxol-induced immune hemolytic anemia. Rev Med Interne 2006;27(10):797-798 (Pubitemid 44470798)
13. Johnson ST, Fueger JT, Gottschall JL. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia - a new paradigm. Transfusion 2007;47(4):697-702 • A comprehensive review of drug-induced immune hemolytic anemia. (Pubitemid 46449631)
14. Martinengo M, Ardenghi DF, Tripodi G, Reali G. The first case of drug-induced immune hemolytic anemia due to hydrocortisone. Transfusion 2008; [Epub ahead of print]
15. Landsteiner K. The Specificity of Serological Reactions. revised, edition, Harvard University Press; 1945
16. Eisen HN, Carsten ME, Belman S. Studies of hypersensitivity to low molecular weight substances. III. The 2,4-dinitrophenyl group as a determinant in the preciptin reaction. J Immunol 1954;73(5):296-308 • An important study on drug - induced immune response.
17. Eisen HN, Kern M, Newton WT, Helmreich E. A study of the distribution of 2,4-dinitrobenzene sensitizers between isolated lymph node cells and extracellular medium in relation to induction of contact skin sensitivity. J Exp Med 1959;110(2):187-206 • An important study on drug - induced immune response.
18. Parker CW. Allergic reactions in man. Pharmacol Rev 1982;34(1):85-104 • A comprehensive review of drug-induced immune hemolytic anemia.
19. Park BK, Coleman JW, Kitteringham NR. Drug disposition and drug hypersensitivity. Biochem Pharmacol 1987;36(5):581-90 • An important study on drug - induced immune response.
20. Ackroyd JF. The pathogenesis of thrombocytopenic purpura due to hypersensitivity to sedormid. Clin Sci Lond 1949;7(3-4):249-285
21. Ackroyd JF. Drug-induced thrombocytopenia. An immunological phenomenon. Vox Sang 1983;45(3):257-9 • A comprehensive review of drug-induced immune hemolytic anemia.
22. Shulman NR. A Mechanism of cell destruction in individuals sensitzized to foreign antigens and its implications in auto-immunity combined clinical staff conference at the national institutes of health. Ann Intern Med 1964;60:506-521
23. Miescher PA, Nydegger U. Drug-induced thrombocytopenias. Blut 1976;32(5):329-336
24. Mueller-Eckhardt C, Salama A. Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus Med Rev 1990;4(1):69-77 •• A comprehensive review of drug-induced immune hemolytic anemia.
25. Salama A, Mueller-Eckhardt C. Immune-mediated blood cell dyscrasias related to drugs. Semin Hematol 1992;29(1):54-63 • A comprehensive review of drug-induced immune hemolytic anemia.
26. Christie DJ, Mullen PC, Aster RH. Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 1985;75(1):310-314 (Pubitemid 15164000)
27. Smith ME, Reid DM, Jones CE, et al. Shulman NR. Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent. J Clin Invest 1987;79(3):912-917 (Pubitemid 17050919)
28. Salama A, Mueller-Eckhardt C. The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. N Engl J Med 1985;313(8):469-74 •• An important study on metabolite - dependent antibodies.
29. Salama A, Mueller-Eckhardt C. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine. Blood 1986;68(6):1285 • An important study on the specifity of drug-dependent antibodies. (Pubitemid 17228804)
30. Salama A, Mueller-Eckhardt C. On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood 1987;69(4):1006-10 • An important study on the specifity of drug-dependent antibodies. (Pubitemid 17080915)
31. Kunicki TJ, Johnson MM, Aster RH. Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome. J Clin Invest 1978;62(3):716-719 (Pubitemid 9006444)
32. Kunicki TJ, Russell N, Nurden AT, et al. Further studies of the human platelet receptor for quinine- and quinine-dependent antibodies. J Immunol 1981;126(2):398-402 (Pubitemid 11136682)
33. Duran-Suarez JR, Martin-Vega C, Argelagues E, et al. Red cell I antigen as immune complex receptor in drug-induced hemolytic anemias. Vox Sang 1981;41(5-6):313-315 (Pubitemid 12245915)
34. Kunicki TJ, Christie DJ, Aster RH. The human platelet receptor(s) for quinine/quinidine-dependent antibodies. Blood Cells 1983;9(2):293-301 (Pubitemid 14248111)
35. Christie DJ, Mullen PC, Aster RH. Quinine- and quinidine platelet antibodies can react with GPIIb/IIIa. Br J Haematol 1987;67(2):213-219 (Pubitemid 18029656)
36. Salama A, Kroll H, Wittmann G, Mueller-Eckhardt C. Diclofenac-induced immune haemolytic anaemia: simultaneous occurrence of red blood cell autoantibodies and drug-dependent antibodies. Br J Haematol 1996;95(4):640-4 • An important study on the incidence and mechanism of drug-induced immune hemolysis. (Pubitemid 26423366)
37. Salama A, Mueller-Eckhardt C, Boschek B, Bhakdi S. Haemolytic 'efficiency' of C5b-9 complexes in drug-induced immune haemolysis: role of cellular C5b-9 distribution. Br J Haematol 1987;65(2):217-222 (Pubitemid 17022809)
38. Habibi B. Drug induced red blood cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias. Br J Haematol 1985;61(1):139-43 • An important study on the mechanism of drug-induced antibodies.
39. Salama A, Göttsche B, Mueller-Eckhardt C. Autoantibodies and drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis. Br J Haematol 1991;77(4):546-549
40. Salama A, Mueller-Eckhardt C. Two types of nomifensine-induced immune haemolytic anaemias: drug-dependent sensitization and/or autoimmunization. Br J Haematol 1986;64(3):613-620 (Pubitemid 17184271)
41. Kerr RO, Cardamone J, Dalmasso AP, Kaplan ME. Two mechanisms of erythrocyte destruction in penicillin-induced hemolytic anemia. N Engl J Med 1972;287(26):1322-1325
42. Ries CA, Rosenbaum TJ, Garratty G, et al. Penicillin-induced immune hemolytic anemia. Occurrence of massive intravascular hemolysis. JAMA 1975;233(5):432-435
43. Salama A, Göttsche B, Schleiffer T, Mueller-Eckhardt C. 'Immune complex' mediated intravascular hemolysis due to IgM cephalosporin-dependent antibody. Transfusion 1987;27(6):460-3 • An important study on the mechanism of drug-induced antibodies.
44. Arndt PA, Mc Gehee W, Garratty G. Cefotaxime-induced immune hemolytic anemia due to antibodies reacting in vitro by more than one mechanism. Transfusion 1990;30(3):263-266 (Pubitemid 20112734)
45. Endoh T, Yagihashi A, Sasaki M, Watanabe N. Ceftizoxime-induced hemolysis due to immune complexes: case report and determination of the epitope responsible for immune complex-mediated hemolysis. Transfusion 1999;39(3):306-309 (Pubitemid 29144917)
46. Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 2000;26(9):1390-4 • An important study on the mechnism of drug-induced antibodies.
47. Calhoun BW, Junsanto T, Donoghue MT, et al. Ceftizoxime-induced hemolysis secondary to combined drug adsorption and immune-complex mechanisms. Transfusion 2001;41(7):893-897 (Pubitemid 32642761)
48. Malloy CA, Kiss JE, Challapalli M. Cefuroxime-induced immune hemolysis. J Pediatr 2003;143(1):130-132 (Pubitemid 36928582)
49. Kakaiya R, Cseri J, Smith S, et al. A case of acute hemolysis after ceftriaxone: immune complex mechanism demonstrated by flow cytometry. Arch Pathol Lab Med 2004;128(8):905-907 (Pubitemid 39014126)
50. Demirkaya E, Atay AA, Musabak U, et al. Ceftriaxone-related hemolysis and acute renal failure. Pediatr Nephrol 2006;21(5):733-736 [Epub 2006 Feb 21]
51. Adachi JD, Bensen WG, Kassam Y, et al. Gold induced thrombocytopenia: 12 cases and a review of the literature. Semin Arthritis Rheum 1987;16(4):287-293 (Pubitemid 17092745)
52. Mueller-Eckhardt G, Giers G, Salama A, et al. Major histocompatibility complex markers in patients with nomifensine-induced immune hemolytic anemia. Vox Sang 1988;54(1):59-61 (Pubitemid 18033621)
53. Long DF, Patton TF, Repta AJ. Platinum levels in human erythrocytes following intravenous administration of cisplatin: importance of erythrocytes as a distribution site for platinum species. Biopharm Drug Dispos 1981;2(2):137-146 (Pubitemid 11095222)
54. Burger KN, Staffhorst RW, De Kruijff B. Interaction of the anti-cancer drug cisplatin with phosphatidyserine in intact and semi-intact cells. Biochim Biophys Acta 1999;1419(1):43-54 (Pubitemid 29257984)
55. Mandal R, Kalke R, Li XF. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group. Chem Res Toxicol 2004;17(10):1391-1397 (Pubitemid 39391217)
56. Petz LD, Fudenberg HH. Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med 1966;274(4):171-8 • An important study on the mechnism of drug-induced antibodies.
57. Branch DR, Berkowitz LR, Becker RL, et al. Extravascular hemolysis following the administration of cefamandole. Am J Hematol 1985;18(2):213-9 • An important study on the mechnism of drug-induced antibodies.
58. Klein H, Anstee D. Mollison's Blood Transfusion in Clinical Medicine. 11th edition
59. Bernasconi C, Bedarida G, Pollini G, Sartori S. Study of the mechanism of hemolysis in a case of acquired hemolytic anemia caused by pyramidon. Haematologica 1961;46:697-720
60. Lindberg LG, Norden A. Severe hemolytic reaction to chlorpromazine. Acta Med Scand 1961;170:195-199
61. Stefanini M, Johnson NL. Positive antihuman globulin test in patients receiving carbromal. Am J Med Sci 1970;259(1):49-55
62. Faulk WP, Tomsovic EJ, Fudenberg HH. Insulin resistance in juvenile diabetes mellitus. Immunologic studies. Am J Med 1970;49(1):133-139
63. Bird GW, Eeles GH, Litchfield JA, et al. Haemolytic anaemia associated with antibodies to tolbutamide and phenacetin. Br Med J 1972;1(5802):728-729
64. Sivamurthy S, Frankfurt E, Levine ME. Positive antiglobulin tests in patients maintained on methadone. Transfusion 1973;13(6):418-421
65. Wenz B, Klein RL, Lalezari P. Tetracycline-induced immune hemolytic anemia. Transfusion 1974;143:265-269
66. Kroovand S, Kirtland HH, Issit CH. A positive direct antiglobulin test due to sodium nafcillin. Transfusion 1977;17:682
67. Wong KY, Boose GM, Issitt CH. Erythromycin-induced hemolytic anemia. J Pediatr 1981;984:647-649 (Pubitemid 11106500)
68. Bird GW, Wingham J, Babb RG, et al. Azapropazone-associated antibodies. Vox Sang 1984;46(5):336-337 (Pubitemid 14129477)
69. De Vecchi A, Zanella A, Egidi F, Ponticelli C. Autoimmune hemolytic anemia in a cadaveric renal transplant recipient treated with cyclosporine. Acta Haematol 1985;73(4):216-218 (Pubitemid 16246692)
70. Gmür J, Wälti M, Neftel KA. Amoxicillin-induced immune hemolysis. Acta Haematol 1985;74(4):230-233 (Pubitemid 16081708)
71. Mathiesen O, Grunnet N. Haemolysis after intravenous streptokinase. Lancet 1989;1(8645):1016-1017 (Pubitemid 19123597)
72. Abad A, López P, Bauza J. Norfloxacin-induced positive direct antiglobulin test. Vox Sang 1999;774:238 (Pubitemid 30050550)
73. Arndt PA, Wolf CF, Kripas CJ, Garratty G. First example of an antibody to ticarcillin: a possible cause of hemolytic anemia. Transfusion 1999;39:47S
74. Pujol M, Fernandez F, Sancho JM, et al. Immune hemolytic anemia induced by 6-mercaptopurine. Transfusion 1973;13:418-421
75. González CA, Guzmán L, Nocetti G. Drug-dependent antibodies with immune hemolytic anemia in AIDS patients. Immunohematol 2003;19(1):10-15 (Pubitemid 36330640)
76. Novaretti MC, Fonseca GH, Conchon M, et al. First case of immune-mediated haemolytic anaemia associated to imatinib mesylate. Eur J Haematol 2003;71(6):455-458 (Pubitemid 37467880)
77. Andersohn F, Bronder E, Klimpel A, Garbe E. Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study. Am J Hematol 2004;77(3):316-8 • An important study on the incidence of drug-induced immune hemolytic anemia.